Gene · 10457
Papers2,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating Cell Type Senescence Signatures Reveal High-Resolution Health Status and Trajectories in Human Longitudinal Studies. | medRxiv | 2026 | 41728302 | PubTator, text mining | PubMed |
| Diversity and function of tumor-associated macrophages in brain metastases: mechanisms and therapeutic prospects. | Front Immunol | 2026 | 41727473 | PubTator, text mining | PubMed |
| Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study. | EBioMedicine | 2026 | 41724112 | PubTator, text mining | PubMed |
| Targeted biologics for TNBC: Advances in nanobodies, antibodies, peptides, and aptamers. | Mol Ther Oncol | 2026 | 41716468 | PubTator, text mining | PubMed |
| RYK is a GPNMB receptor that drives MASH. | Nature | 2026 | 41708863 | PubTator, text mining | PubMed |
| Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635. | Clin Transl Sci | 2026 | 41708347 | PubTator, text mining | PubMed |
| Human microglia in brain assembloids display region-specific diversity and respond to hyperexcitable neurons carrying SCN2A mutation. | Sci Adv | 2026 | 41706855 | PubTator, text mining | PubMed |
| The temporal and stimuli-specific effects of LPS and IFNγ on microglial activation. | Front Aging Neurosci | 2026 | 41695273 | PubTator, text mining | PubMed |
| ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases. | Mod Pathol | 2026 | 41690476 | PubTator, text mining | PubMed |
| Glycoprotein non-metastatic melanoma protein B promotes pyroptosis of macrophages induced by homocysteine associated with the upregulation of the NOX-2/ NF-κB signaling pathway. | Cell Signal | 2026 | 41690438 | PubTator, text mining | PubMed |
| Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency). | Mayo Clin Proc | 2026 | 41686095 | PubTator, text mining | PubMed |
| Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies. | medRxiv | 2026 | 41646722 | PubTator, text mining | PubMed |
| Sex-Associated Biomarker Differences in CKD Progression and Mortality. | Clin J Am Soc Nephrol | 2026 | 41642662 | PubTator, text mining | PubMed |
| Single-cell analysis reveals neuroprotective histone deacetylase inhibitor pathways. | Alzheimers Dement | 2026 | 41630642 | PubTator, text mining | PubMed |
| Altered Cerebrospinal Fluid Tryptophan-Kynurenine Pathway Metabolism in Multiple System Atrophy. | Mov Disord | 2026 | 41623185 | PubTator, text mining | PubMed |
| Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. | J Immunother Cancer | 2026 | 41617396 | PubTator, text mining | PubMed |
| Partial-EMT in oral squamous cell carcinoma: molecular circuitry and clinical translation. | Int J Oral Sci | 2026 | 41611665 | PubTator, text mining | PubMed |
| Multi-platform integration of brain and CSF proteomes reveals biomarker panels for Alzheimer's disease. | Brief Bioinform | 2026 | 41608987 | PubTator, text mining | PubMed |
| stGCL: a versatile cross-modality fusion method based on multi-modal graph contrastive learning for spatial transcriptomics. | Genome Biol | 2026 | 41606649 | PubTator, text mining | PubMed |
| Defining the cellular and molecular identities of histologic subtypes in lung adenocarcinoma. | Exp Hematol Oncol | 2026 | 41578368 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10457/papers?page=6